MRI-guided Neurosurgical Ablation Market

MRI-guided Neurosurgical Ablation Market Outlook (2023 to 2033)

The global MRI-guided neurosurgical ablation market is valued at US$ 598.99 million in 2023. As per this new study by Fact.MR, global demand for MRI-guided neurosurgical ablation systems is expected to increase at a CAGR of 8% and reach a market valuation of US$ 1.29 billion by 2033.

Brain tumours can be treated with the minimally-invasive neurosurgical procedure known as MRI-guided laser ablation. Lasers are employed during the procedure to pinpoint and eradicate or ablate the tumour. MRI-guided ablation, as opposed to conventional open surgery (craniotomy), can lessen post-operative pain and hasten recovery.

Furthermore, glioblastoma, a critically aggressive glioma tumour that regularly recurs and can be fatal, is one of the more difficult tumours for surgeons to treat. This tumour can be managed by MRI-guided ablation. The ablation procedure might make it simpler for neurosurgeons to address some cancers that are near delicate tissues or buried deep inside the skull and difficult to access using a standard open craniotomy.

The main factors anticipated to drive the market growth are the rising prevalence of brain tumours and other nervous system-related ailments as well as the expanding use of minimal-invasive neurosurgeries.

• According to projections from Globocan 2020, there were 308,102 new instances of brain cancer worldwide in 2021, and there were 251,329 new fatalities in the same year.

MRI-guided neurosurgical ablation systems are segmented into RF ablation systems, laser ablation systems, focused ultrasound systems, and accessories. Global sales of RF ablation systems are predicted to rise at a CAGR of 9% during the forecast period.

The process of ablating involves removing undesirable organs, aberrant growths, or dangerous chemicals from the human body. By using high-frequency alternating currents given by bipolar or unipolar catheters, ablation is the elimination of a nerve transmission route. A non-surgical therapy called radiofrequency (RF) ablation uses radio waves or electric currents to disrupt nerve connectivity.

Radiofrequency ablation operates based on disrupting the conduction of neural signals, specifically the nerve signals that carry pain. A scar tissue that blocks the nerve conduction channel is formed as a result of the heat produced by the electric current.

Radiofrequency ablation system demand is anticipated to increase at a rapid pace as radiofrequency ablation procedures are less expensive than other ablation techniques and have higher safety, efficacy, and shorter procedure times for treatment and pain management.

Report Attributes	Details
MRI-guided Neurosurgical Ablation Market Size (2023E)	US$ 598.99 Million
Forecasted Market Value (2033F)	US$ 1.29 Billion
Global Market Growth Rate (2023 to 2033)	8% CAGR
China Market Growth Rate (2023 to 2033)	11.5% CAGR
Japan Market Growth Rate (2023 to 2033)	4.5% CAGR
Germany Market Growth Rate (2023 to 2033)	5% CAGR
Canada Market Growth Rate (2023 to 2033)	7% CAGR
Key Companies Profiled	AngioDynamics Inc; Boston Scientific Corporation; Insightec Ltd; Medtronic PLC; Monteris Medical Inc; MRI Intervention Inc.

Which market Trends are Benefiting Suppliers of MRI-guided Neurosurgical Ablation Systems?

“Rising Demand for Minimally-invasive Surgeries”

Fact.MR, a market research and competitive intelligence provider, offers a comparative analysis of the sales growth rates and development possibilities in the global MRI-guided neurosurgical ablation market. Regulatory approvals and innovative considerations have a significant impact on the market.

In recent years, MRI-guided minimally-invasive neurosurgery procedures have gained a lot of pace due to innovations such as the MRI intervention neurosurgical navigation platform and MRI-guided laser ablation platforms. Most of these MRI-guided systems are utilised in typical diagnostic MRI facilities.

A growing rate of MRI-guided laser ablation treatments is being carried out by clinicians nowadays as part of routine clinical practice. The demand for MRI-guided neurosurgical ablation products is expected to grow in the coming years due to the increasing use of MRI guidance in several minimally-invasive procedures for a wide range of patients.

Demand for MRI-guided neurosurgical ablation technologies is anticipated to increase over the coming years due to rising cases of brain cancer. The development of MRI-guided systems is centred on the field of neurosurgery, and the introduction of MRI-guided laser interstitial thermal treatment (LITT) is anticipated to support the growth of the market for MRI-guided neurosurgical ablation.

“Increasing Awareness Campaigns Regarding Brain Cancer”

Several governments and private organizations across the globe are launching various campaigns to raise awareness of early brain problem diagnosis and treatment.

• The month of May, for instance, has been designated as ‘Brain Tumor Awareness Month’. The National Brain Tumor Society has launched a campaign called ‘It's Your Fight, It's Our Fight’ intending to enlighten and involve the public in activities that may promote awareness of and find a cure for brain tumours.
• Similar to this, the HeadSmart National Awareness Campaign, sponsored by the Brain Tumor Charity, aims to cut the time it takes to diagnose cancer and brain tumours to 4 weeks or less. People are becoming more aware of the diagnostic and treatment options, which are anticipated to boost sales growth.

Which Obstacles Need to Be Tackled by Manufacturers of MRI-guided Neurosurgical Ablation Systems?

“Lack of Understanding about Handling Advanced Ablation Systems”

Several firms are introducing advanced ablation systems but due to a lack of handling knowledge, the users are more interested in using conventional systems. Thus, the magnetic resonance imaging (MRI)-guided neurosurgical ablation market growth is predicted to be constrained by a lack of skilled and trained professionals as well as the high cost of this procedure.

On the other hand, lack of knowledge regarding the treatment procedures of brain tumours could also pose a threat to product sales growth.

Country-wise Analysis

What is Supporting the United States Market in Growing Rapidly?

“Introduction of Advanced Ablation Systems by Key Market Players”

MRI-guided neurosurgical ablation system sales in the United States are anticipated to be boosted by the presence of major key players and their investments in this sector. The demand for MRI-guided neurosurgical ablation devices in the nation is being fueled by the introduction of cutting-edge technologies, a robust healthcare infrastructure, increasing incidences of central nervous system cancer, and the existence of highly skilled and experienced neurosurgeons.

High spending power on healthcare and improved outpatient facilities are also driving market growth in the United States.

How are Sales of MRI-guided Neurosurgical Ablation Equipment Progressing in China & Japan?

“Rising Medical Tourism and Increasing Prevalence of Glioblastoma”

China's demand for MRI-guided neurosurgical ablation equipment is anticipated to rise at a considerable growth rate over the projection period due to the high patient population, rising healthcare costs, and increasing medical tourism. It is anticipated that the sales growth in this market will develop at a rapid pace as a result of the substantial distribution of healthcare spending for hospitals and the supply of medications to the elderly population.

The most prevalent type of brain tumour in Japan is glioblastoma (GBM), which is well known for having one of the worst prognoses of any malignancy. Thus rising cases of glioblastoma are boosting sales growth in Japan. Sales of MRI-guided neurosurgical ablation products are expected to progress at a CAGR of 4.5% from 2023 to 2023.

Which Strategies are Adopted by Manufacturers in the United Kingdom to Develop Improved RF Ablation Systems?

“Investments in R&D and Partnerships with Other Market Players”

Leading businesses and medical institutes in the United Kingdom are investing more in research and development to create cutting-edge radiofrequency ablation (RF) devices, which are anticipated to boost market growth over the projected period. To compete in the market, numerous other businesses are also hoping to enter into joint ventures and collaborations.

• A team of researchers at the University College, London created an MRI-guided thermoset that permits precise targeting of malignancies before the onset of ablation, according to a research study released in February 2022 by the National Center for Biotechnology Information (NCBI). Thus, ongoing research projects are expected to boost the sales of MRI-guided neurosurgical ablation systems.

Category-wise Analysis

Why Do Hospitals Dominate the Sales of MRI-guided Neurosurgical Ablation Systems?

“Availability of Skilled Medical Experts and Advanced Healthcare Facilities”

Hospitals are anticipated to dominate the demand for MRI-guided neurosurgical ablation systems due to the high rate of patient intake seeking brain cancer treatment. The cases of central nervous system cancer are rising, and hospitals are well-equipped to treat patients with such conditions. Thus, hospitals with all the necessary equipment and cutting-edge healthcare infrastructure are boosting the sales growth of MRI-guided neurosurgical ablation technologies.

Hospitals are more affordable, and their expert staff, which includes neurosurgeons, senior doctors, and other qualified and experienced support staff, may complete surgery faster. All of these factors encourage people to visit hospitals for advanced medical care, which raises the need for MRI-guided neurosurgical ablation devices.

Also, demand for MRI-guided neurosurgical ablation devices from ambulatory surgical centers is expected to increase at a high pace during the forecast period. This can be attributed to the fact that they offer same-day medical procedures and don't require patients to stay overnight.

Due to the lower risk of complications, ambulatory surgical centers (ASCs) typically undertake non-invasive surgical treatments. Compared to open surgeries, minimally-invasive surgeries cause the body less harm.

For brain tumours, the majority of ASCs employ MRI-guided neurosurgical ablation equipment, which enables doctors to perform MRI-guided laser surgeries. This surgical procedure provides a quicker recovery period than the conventional approach. Thus, all such aspects are expected to boost the demand for MRI-guided neurosurgical ablation systems during the next 10 years.

Competitive Landscape

To gain a competitive edge, businesses are concentrating on research and development to create technologically improved products. The main motive of key market players is to improve product quality standards.

• For instance, the ClearPoint PURSUIT Neuro Aspiration system was approved by the U.S. FDA in January 2019 for MRI Interventions, Inc., a neurosurgical business. This tool was created in collaboration with the Mayo Clinic and is intended for the aspiration of abscesses, cerebral spinal fluid, clots, and cystic tumours.
• Similar to this, in April 2018, Medtronic announced the introduction of the Visualase MRI-Guided Laser Ablation System to the European market. This minimally-invasive laser therapy is intended for the treatment of brain problems and accurately targets and treats small portions of undesirable tissue.

Several companies are engaging in mergers, collaborations, and acquisitions to expand their product lines, increase their manufacturing capabilities, improve supply chain management, and offer a wider range of competitive advantages.

• For instance, Insightec raised US$ 150 million in March 2020 for the development of incisionless surgical equipment used for treating tremors in individuals with tremor-dominant Parkinson's disease (PD) who are not responding to medicines.
• Accurian, a brand-new radiofrequency ablation technology from Medtronic, was introduced in February 2019. The new system has hardware, cutting-edge temperature control software, and a quad-core processor built to provide efficiency in standard, pulsed, and enhanced procedures.

MRI-guided Neurosurgical Ablation Industry Research Segments

• By Product:

  • RF Ablation Systems
  • Laser Ablation Systems
  • Focused Ultrasound Systems
  • Accessories

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research Laboratories

• By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA